Platelet derived growth factor (Amgen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePlatelet derived growth factor (Amgen)
Drug Alias NamerPDGF Bc-sis
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionPlatelet-derived growth factor receptor agonists
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsPressure Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsPressure Ulcer

Other Information

ATC CodeN/A
Related LinksN/A